Health Care Transition Readiness Short-Form Video Intervention

May 8, 2026 updated by: Caitlin Sayegh, Children's Hospital Los Angeles

Transition Readiness Mobile Health Intervention: Co-Design and Pilot Study

The goal of this clinical trial is to assess whether social-media style short-form health education videos can increase health care transition readiness, self-efficacy, emotional well-being, health literacy, and appointment attendance, compared with publicly available health education resources in adolescents with chronic illnesses. The main question it aims to answer is:

-Hypothesize social media intervention will increase health care transition readiness, self-efficacy, emotional well-being, health literacy, and appointment attendance compared to publicly available health education website immediately post intervention and at 6 month follow up.

Participants will be randomly assigned to one of the interventions and access the intervention for 20 minutes and complete 30-60 minutes of surveys.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • United States
    • California
      • Los Angeles, California, United States, 90027
        • Recruiting
        • Children Hospital Los Angeles
        • Principal Investigator:
          • Caitlin Sayegh, PhD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients in subspecialty clinics
  • Between 12 and 17 years old
  • With access to an internet-connected device
  • Speaking English or Spanish
  • With sufficient cognitive capacity to understand the study procedures, as assessed via a teach back method.

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Health education videos
The social media intervention will consist of 7 short videos between 20-60 seconds each, filmed by a professional videographer. Videos 1) start with text asking a question or giving a title highlighting the educational topic, 2) display adolescent volunteer patient partners directly teaching self-management and transition skills, demonstrating the skills via tutorials, or presenting health education content in the style of social media trends, and 3) conclude with a written summary of take-away points. The videos will be shared to participants as a password-protected Vimeo.com playlist. If participants are more comfortable in Spanish, they will be given the option to view the videos dubbed in Spanish.
Behavioral: Health Education Videos
Participants will be prompted to explore the 7 health education videos for up to 20 minutes.
Active Comparator: Publicly Available Health Education Website
The social media intervention will be contrasted against a control condition consisting of sharing the GotTransition.org Youth and Young Adult Resources webpage: https://gottransition.org/youth-and-young-adults/. This website is a project from The National Alliance to Advance Adolescent Health. The webpage includes videos, infographics, quizzes, and frequently asked questions. Testing the social media intervention against this existing national resource will assess whether the novel intervention is relatively more acceptable or efficacious than an active comparison. If participants are more comfortable in Spanish, a prompt will be provided to them to use the website search function to locate resources in Spanish.
Behavioral: GotTransition.org Website
Participants will be prompted to explore the Gottransition.org website for up to 20 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported score with a range from 1-5, on the Transition Readiness Assessment Questionnaire (TRAQ).
Time Frame: Immediate post-treatment and 6-month follow-up.
The TRAQ assesses the readiness of youth and young adults to transition from pediatric to adult healthcare. It includes items related to managing medications, appointment keeping, tracking health issues, and communicating with healthcare providers.
Immediate post-treatment and 6-month follow-up.
Self-reported score ranging from 1 to 4, via the Generalized Self-Efficacy Scale (GSES).
Time Frame: Immediate post-treatment and 6-month follow-up.
The GSES evaluates an individual's belief in their ability to cope with a variety of difficult demands in life. It consists of 10 items, each rated on a 4-point scale, assessing confidence in handling unexpected events and solving problems.
Immediate post-treatment and 6-month follow-up.
Self-reported score ranging from 1 to 5, via the Positive and Negative Affect Schedule for Children and Adolescents (PANAS-C).
Time Frame: Immediate post-treatment and 6-month follow-up.
The PANAS-C measures positive and negative affect in children and adolescents. It includes items that assess the extent to which individuals experience various positive and negative emotions over the past few weeks.
Immediate post-treatment and 6-month follow-up.
Self-report questionnaire with a score ranging from 10 to 40, via the Health Literacy for Youth.
Time Frame: Immediate post-treatment and 6-month follow-up.
The HLSAC measures subjective health literacy in youth, focusing on their ability to access, understand, and use health information to make informed decisions.
Immediate post-treatment and 6-month follow-up.
Number of appointments attended divided by the number of appointments scheduled, producing a score ranging from 0 to 100%, via medical chart abstraction.
Time Frame: Comparing 6 months before intervention to 6 months after intervention.
This measure calculates the percentage of scheduled medical appointments that were attended by the patient, providing insight into adherence to treatment plans and engagement with healthcare services.
Comparing 6 months before intervention to 6 months after intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Children's Hospital Los Angeles

Investigators

  • Principal Investigator: Caitlin S Sayegh, PhD, Children's Hospital Los Angeles

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

February 19, 2025

First Submitted That Met QC Criteria

February 19, 2025

First Posted (Actual)

February 24, 2025

Study Record Updates

Last Update Posted (Actual)

May 12, 2026

Last Update Submitted That Met QC Criteria

May 8, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CHLA-21-00158

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

To protect patient confidentiality, we will not share data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Self Efficacy

Clinical Trials on Health Education Videos

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe